Investor Presentaiton slide image

Investor Presentaiton

The diversification strategy with new products (NPD) have generated excellent sales growth and set solid fundamental for the future • NPD has grown more than 140% qoq as of 3Q21, supported by strong sales of Vitamin C1000 new flavour and RTD variants, also by new supplement products (soft gel, JSH, Sambilito, etc.). NPD contributes 4% of total consolidated sales. • For the last 3 years, SIDO new products have grown significantly by 51% CAGR, without cannibalizing the existing products as each of the new products addresses different symptoms and efficacies. SIDOMUNCUL Positive sales trend on NPD* (IDR bn) 70 60 50 HN WAGON 10 40 30 20 SALES CAGR 2017-2020 NEW PRODUCTS SIDO 9% HERBAL 10% F&B 8% *New Products launched in 2020-2021 51% 3Q20 4Q20 1Q21 2Q21 3Q21 Vit C is the top contributors of NPD* VIT C1000 66% OTHER 7% SUPPLEMENT 27% 24
View entire presentation